LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MCF7 | Pictilisib | 10.0 | uM | LJP6 | 3 | D19 | 72 | hr | 1235 | 1284 | 4156 | 0.3089 | 0.0166 |
| MCF7 | Gefitinib | 10.0 | uM | LJP6 | 1 | N07 | 72 | hr | 1235 | 3650 | 4156 | 0.8782 | 0.8267 |
| MCF7 | Gefitinib | 10.0 | uM | LJP6 | 2 | N07 | 72 | hr | 1235 | 2972 | 4156 | 0.7151 | 0.5946 |
| MCF7 | Gefitinib | 10.0 | uM | LJP6 | 3 | N07 | 72 | hr | 1235 | 3711 | 4156 | 0.8929 | 0.8476 |
| MCF7 | Geldanamycin | 10.0 | uM | LJP5 | 1 | O01 | 72 | hr | 1235 | 544 | 4156 | 0.1309 | -0.2367 |
| MCF7 | Geldanamycin | 10.0 | uM | LJP5 | 2 | O01 | 72 | hr | 1235 | 483 | 4156 | 0.1162 | -0.2576 |
| MCF7 | Geldanamycin | 10.0 | uM | LJP5 | 3 | O01 | 72 | hr | 1235 | 550 | 4156 | 0.1323 | -0.2347 |
| MCF7 | Geldanamycin | 10.0 | uM | LJP6 | 1 | O01 | 72 | hr | 1235 | 479 | 4156 | 0.1153 | -0.2590 |
| MCF7 | Geldanamycin | 10.0 | uM | LJP6 | 2 | O01 | 72 | hr | 1235 | 608 | 4156 | 0.1463 | -0.2148 |
| MCF7 | Geldanamycin | 10.0 | uM | LJP6 | 3 | O01 | 72 | hr | 1235 | 571 | 4156 | 0.1374 | -0.2275 |
| MCF7 | GSK1059615 | 10.0 | uM | LJP5 | 1 | E01 | 72 | hr | 1235 | 792 | 4156 | 0.1906 | -0.1518 |
| MCF7 | GSK1059615 | 10.0 | uM | LJP5 | 2 | E01 | 72 | hr | 1235 | 751 | 4156 | 0.1807 | -0.1658 |
| MCF7 | GSK1059615 | 10.0 | uM | LJP5 | 3 | E01 | 72 | hr | 1235 | 763 | 4156 | 0.1836 | -0.1617 |
| MCF7 | GSK1059615 | 10.0 | uM | LJP6 | 1 | C01 | 72 | hr | 1235 | 689 | 4156 | 0.1658 | -0.1871 |
| MCF7 | GSK1059615 | 10.0 | uM | LJP6 | 2 | C01 | 72 | hr | 1235 | 777 | 4156 | 0.1870 | -0.1569 |
| MCF7 | GSK1059615 | 10.0 | uM | LJP6 | 3 | C01 | 72 | hr | 1235 | 706 | 4156 | 0.1699 | -0.1813 |
| MCF7 | GSK1904529A | 10.0 | uM | LJP6 | 1 | H19 | 72 | hr | 1235 | 1556 | 4156 | 0.3744 | 0.1098 |
| MCF7 | GSK1904529A | 10.0 | uM | LJP6 | 2 | H19 | 72 | hr | 1235 | 1747 | 4156 | 0.4203 | 0.1752 |
| MCF7 | GSK1904529A | 10.0 | uM | LJP6 | 3 | H19 | 72 | hr | 1235 | 1925 | 4156 | 0.4632 | 0.2361 |
| MCF7 | Omipalisib | 10.0 | uM | LJP6 | 1 | N01 | 72 | hr | 1235 | 827 | 4156 | 0.1990 | -0.1398 |
| MCF7 | Omipalisib | 10.0 | uM | LJP6 | 2 | N01 | 72 | hr | 1235 | 853 | 4156 | 0.2052 | -0.1309 |
| MCF7 | Omipalisib | 10.0 | uM | LJP6 | 3 | N01 | 72 | hr | 1235 | 788 | 4156 | 0.1896 | -0.1532 |
| MCF7 | GSK 690693 | 10.0 | uM | LJP5 | 1 | F19 | 72 | hr | 1235 | 1956 | 4156 | 0.4706 | 0.2467 |
| MCF7 | GSK 690693 | 10.0 | uM | LJP5 | 2 | F19 | 72 | hr | 1235 | 2018 | 4156 | 0.4855 | 0.2680 |
| MCF7 | GSK 690693 | 10.0 | uM | LJP5 | 3 | F19 | 72 | hr | 1235 | 2454 | 4156 | 0.5905 | 0.4172 |